Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
SGHT Transcript
Sight Sciences, Inc. (SGHT) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Neutral5-13
Sight Sciences, Inc. (SGHT) Q1 2026 Earnings Call Transcript
Positive5-7
The company reported strong revenue growth of 15% YoY and improved gross margins, which are positive indicators. The raised revenue guidance for 2026 further supports a positive outlook. Although operating expenses increased, they were driven by strategic investments in R&D and sales, which could foster future growth. The reduction in net loss and improved margins are encouraging, suggesting operational efficiency. Despite the lack of discussion on shareholder returns and operational updates, the overall sentiment leans positive due to strong financial performance and optimistic guidance.
Sight Sciences, Inc. (SGHT) Q4 2025 Earnings Call Transcript
Positive3-4
The earnings call highlights several positive developments: raised revenue guidance, reduced operating expenses, and significant market opportunities in the dry eye segment. Despite some cautious guidance and uncertainties in reimbursement and market access, the company's strategic focus and expected cost savings position it for growth. The Q&A session supports this with a generally positive sentiment from analysts, despite some vague responses from management. Overall, the positive aspects outweigh the negative, leading to a positive stock price outlook over the next two weeks.
Sight Sciences, Inc. (SGHT) Q3 2025 Earnings Call Transcript
Positive11-6
The company has shown improved financial performance with reduced operating expenses and net loss. Raised revenue guidance and strategic focus on TearCare's growth potential indicate optimism. Despite some uncertainties in the Q&A, the engagement and expansion plans for TearCare and the MIGS market suggest positive sentiment. The market's reaction is likely to be positive, considering the strategic initiatives and financial improvements.
SGHT Slides
SGHT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
